xxx
 
Print This Page
Share this page: More
 

Skull Base Olfactory Neuroblastoma (Esthesioneuroblastoma)

What is an olfactory neuroblastoma (esthesioneuroblastoma)?

Olfactory neuroblastomas, also known as esthesioneuroblastomas, are very rare, malignant tumors that develop in the nose. These tumors are believed to start in the olfactory nerve, which transmits impulses related to smell from the nose to the brain.

olfactory neuroblastoma pre-op
Pre-op image of olfactory
neuroblastoma (esthesioneuroblastomas)
olfactory neuroblastoma post-op
Post-op image of olfactory
neuroblastoma (esthesioneuroblastomas)

Symptoms of an olfactory neuroblastoma (esthesioneuroblastoma):

The following are the most common symptoms of an olfactory neuroblastoma (esthesioneuroblastoma). However, an individual may experience symptoms differently.

Symptoms may include the following:

  • nasal obstruction
  • nosebleed (epistaxis)
  • changes in sense of smell (hyposmia)
  • nasal discharge
  • facial pain
  • changes in vision
  • excessive tearing from the eyes (lacrimation)
  • facial numbness
  • neck mass

Treatment for an olfactory neuroblastoma (esthesioneuroblastoma):

Treatment for an olfactory neuroblastoma (esthesioneuroblastoma) may include surgery, radiation therapy, and possibly chemotherapy. The surgical approaches most often used to remove this type of brain tumor includes the transcranial approaches and the endoscopic transnasal approaches.

To make an appointment or request a consultation, contact the Johns Hopkins Skull Base Tumor Center at 410-614-0585.

 

Ranked #1 Neurology & Neurosurgery in the US

US News and World Report Best HospitalsJohns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row. Johns Hopkins Neurology and Neurosurgery is also ranked #1 in the nation.

Related Links

Chordoma: Drug screening starts to find new treatment for rare bone cancer
The Chordoma Foundation has awarded a $200,000 grant to Dr. Gary Gallia, a skull-base neurosurgeon and cancer biologist at Johns Hopkins. Gallia’s focus is on developing new therapies for brain and skull-based tumors. His lab has a long record of studying mouse models of brain tumors and he has developed a xenograft mouse model to study chordoma.

National Cancer Institute Comprehensive Cancer Center

The Johns Hopkins Comprehensive Brain Tumor Center is a National Cancer Institute (NCI) designated Comprehensive Cancer Center.
NCI designated Comprehensive Cancer Canter

 

Related Articles

The Hunt for a Brain Tumor Vaccine

Letting the Hounds Loose on Brain Tumors

Turning the Tables on Brain Tumors

Make a Gift - Find Out More

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

Privacy Policy and Disclaimer